Katrin Burkart, PhD, is an Assistant Professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. In this role, she works on the Global Burden of Disease (GBD) project, conducting research on environmental risks and methods to include exposure to suboptimal temperature. Dr. Burkart is also working on projections of future temperature-related mortality under climate and population change scenarios. In addition to accounting for rising temperatures, she is particularly interested in incorporating the dynamics of global change, especially demographic and epidemiological change as well as urbanization into her estimations and projections.
Before coming to the University of Washington, Dr. Burkart was a Postdoctoral Research Scientist in the Department of Environmental Health Sciences at the Mailman School of Public Health at Columbia University in New York. Dr. Burkart received her doctorate from the Humboldt Universität zu Berlin, Germany, where she conducted research on the short- and long-term impacts of temperature and thermal conditions on human mortality in Bangladesh. She is particularly interested in understanding how temperature impacts are modified by regional, spatial, or population-specific characteristics. Dr. Burkart has published several papers on effect modifications by demographic characteristics, such as age and socioeconomic status, as well as intra-urban and urban-rural differences. In recent studies, she highlighted interactive effects between air pollution and high temperatures and pointed at the role of urban vegetation in heat effect mitigation.
IHME was established at the University of Washington in Seattle in 2007. Its mission is to improve health through better health evidence.
Burkart KG, Brauer M, Aravkin AY, Godwin WW, Hay SI, He J, Iannucci VC, Larson SL, Lim SS, Liu J, Murray CJL, Zheng P, Zhou M, Stanaway JD. Estimating the cause-specific relative risks of non-optimal temperature on daily mortality: a two-part modelling approach applied to the Global Burden of Disease Study. The Lancet. 19 August 2021. doi: 10.1016/S0140-6736(21)01700-1.
GBD 2019 Under-5 Mortality Collaborators. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. The Lancet. 17 August 2021. doi: 10.1016/S0140-6736(21)01207-1.
GBD 2019 Chewing Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet Public Health. 27 May 2021. doi: 10.1016/S2468-2667(21)00065-7.
GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet. 27 May 2021. doi: 10.1016/S0140-6736(21)01169-7.
India State-Level Disease Burden Initiative Air Pollution Collaborators. The health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019. The Lancet Planetary Health. 21 December 2020. doi:10.1016/S2542-5196(20)30298-9.
India State-Level Disease Burden Initiative Air Pollution Collaborators. The impact of air pollution on deaths, disease burden, and life expectancy across the states of India: the Global Burden of Disease Study 2017. The Lancet Planetary Health. 5 Dec 2018. doi: https://doi.org/10.1016/S2542-5196(18)30261-4